Thomas P. Mathers, Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (CLCD), bought 7,500 shares at $7.10 ($53K) on 2015-08-25, disclosed to the SEC on 2015-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CLCD | SELL | 2016-11-07 | $43K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $111K | — | Filing → |
| CLCD | SELL | 2016-09-16 | $140K | — | Filing → |